Drug Stability - Pharmacy Technician Certification Exam Ptce

1. Identify the correct storage term for $20\deg ree\text{C}$ to $25\deg ree\text{C}$ on a medication label.

   Controlled room temperature ($20\deg ree\text{C}$ to $25\deg ree\text{C}$). USP defines this range as controlled room temperature to ensure stability for most medications without extreme fluctuations.

2. What is the typical in-use expiration for most insulin products at room temperature after first use?

   About 28 days (verify specific product labeling). Manufacturers determine this period based on stability testing to ensure insulin remains potent and safe at ambient conditions post-opening.

3. What is the USP default BUD for a water-containing topical/dermal formulation (no stability data)?

   30 days (or intended duration, whichever is shorter). USP <795> sets this limit for topical water-containing compounds to prevent degradation and contamination without specific stability information.

4. What is the typical in-use expiration for insulin glulisine (Apidra) after first use?

   Typically 28 days in-use (verify product labeling). Apidra's stability is confirmed for this duration to prevent degradation after opening.

5. What does the label instruction "Do not freeze" imply for storage and stability risk?

   Freezing can inactivate/denature; keep above freezing. Freezing may cause protein denaturation in biologics, so storage must avoid temperatures below freezing to preserve efficacy.

6. What is the USP default BUD for a nonaqueous formulation (no stability data)?

   90 days (or intended duration, whichever is shorter). USP <795> allows longer stability for nonaqueous forms due to lower risk of microbial growth and chemical instability without water.

7. What is the key dating event for most multi-dose insulin vials or pens: first puncture or first refrigeration?

   First use (first puncture/first opening) starts in-use dating. In-use stability periods begin upon first access to account for potential contamination and degradation from repeated entries.

8. What is the default beyond-use date (BUD) for a nonpreserved reconstituted oral liquid stored cold?

   14 days refrigerated (USP default for water-containing oral liquids). USP <795> guidelines specify this timeline to ensure microbial stability in water-based formulations without preservatives under cold storage.

9. What is the typical in-use expiration for insulin glargine (Basaglar) pen after first use?

   Typically 28 days in-use (verify product labeling). Basaglar, as a biosimilar to Lantus, follows similar stability profiles validated by manufacturer labeling.

10. What is the typical in-use expiration for insulin aspart (NovoLog) vial or pen after first use?

    Typically 28 days in-use (verify product labeling). NovoLog's rapid-acting formulation is stable for this period at room temperature, per manufacturer guidelines.

11. What is the typical in-use expiration for insulin regular (Humulin R/Novolin R) vial after first use?

    Typically 31 days (varies by product; verify labeling). Regular insulin formulations like Humulin R and Novolin R have slight variations but typically align around this period based on testing.

12. Which insulin is commonly labeled for an in-use period of 56 days: insulin degludec (Tresiba) or NPH?

    Insulin degludec (Tresiba): typically 56 days in-use. Tresiba's ultra-long-acting formulation supports prolonged stability at room temperature, validated by manufacturer data.

13. What is the typical in-use expiration for most insulin pens at room temperature after first use?

    About 28 days (verify specific pen labeling). Pen devices have specific in-use durations validated by manufacturers to maintain insulin integrity despite device mechanics and exposure.

14. Identify the correct action if an insulin vial has been frozen and thawed, even if it looks normal.

    Discard; frozen insulin is considered compromised. Freezing causes irreversible damage to insulin proteins, rendering it ineffective and unsafe for use.

15. What is the typical in-use expiration for insulin glargine (Semglee) after first use?

    Typically 28 days in-use (verify product labeling). Semglee, interchangeable with Lantus, adheres to equivalent in-use stability based on regulatory approval.

16. Identify the correct storage term for $2\deg ree\text{C}$ to $8\deg ree\text{C}$ on a medication label.

    Refrigerated ($2\deg ree\text{C}$ to $8\deg ree\text{C}$). This temperature range defines refrigeration per USP standards to maintain drug potency and prevent degradation in sensitive products.

17. What is the USP default BUD for a manufactured bottle of tablets/capsules after opening (no stability data)?

    Use manufacturer expiration date (do not shorten by default). Manufactured solid dosage forms retain full expiration upon opening per USP unless data indicates otherwise, ensuring safe use.

18. Find the correct BUD: A reconstituted oral suspension is stored in the refrigerator with no other data.

    14 days refrigerated. USP default ensures safety for reconstituted suspensions without specific data by limiting exposure time under refrigeration.

19. What is the typical in-use expiration for insulin lispro U-200 (Humalog U-200) pen after first use?

    Typically 28 days in-use (verify product labeling). Humalog U-200's stability is tested to maintain potency for this duration at room temperature after initial use.

20. Which label statement most directly determines stability for a reconstituted antibiotic: USP defaults or package insert?

    Package insert instructions supersede USP defaults. Manufacturer-specific instructions in the package insert provide tested stability data that override general USP guidelines for accuracy.

21. What is the typical in-use expiration for insulin glargine (Lantus) vial or pen after first use?

    Typically 28 days in-use (verify product labeling). Lantus stability testing confirms this period ensures efficacy and safety post-first use under labeled conditions.

22. What is the typical in-use expiration for insulin aspart (Fiasp) vial or pen after first use?

    Typically 28 days in-use (verify product labeling). Fiasp includes excipients for faster absorption but maintains standard in-use stability as tested.

Study these flashcards